Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.

Literature DB >> 520404

Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.

V Ala-Hurula, V V Myllylä, P Arvela, N T Kärki, E Hokkanen.

Abstract

Entities: Chemical

Mesh：

Substances：
Suppositories
Ergotamine

Year: 1979 PMID： 520404 DOI： 10.1007/BF00605636

Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN： 0031-6970 Impact factor: 2.953

× No keyword cloud information.

10 in total

1. Ergotamine tolerance in patients with migraine.

Authors: A P FRIEDMAN; T J VON STORCH
Journal: J Am Med Assoc Date: 1955-03-12

2. A new look at the use of ergotamine.

Authors: J M Bradfield
Journal: Drugs Date: 1976-12 Impact factor: 9.546

3. About the fate of natural and dihydrogenated ergot alkaloids in the organism.

Authors: E ROTHLIN
Journal: Schweiz Med Wochenschr Date: 1947-11-01

4. Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine.

Authors: E Müller-Schweinitzer
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1976 Impact factor: 3.000

Review 5. Migraine. I. Classification and pathogenesis.

Authors: J R Saper
Journal: JAMA Date: 1978-06-02 Impact factor: 56.272

6. Ergotamine induced headaches in migrainous patients.

Authors: A R Rowsell; C Neylan; M Wilkinson
Journal: Headache Date: 1973-07 Impact factor: 5.887

7. 9-10-dihydroergotamine: production of antibodies and radioimmunoassay.

Authors: J Rosenthaler; H Munzer
Journal: Experientia Date: 1976-02-15

8. Toxic effects of ergotamine used for migraine.

Authors: E Hokkanen; O Waltimo; T Kallanranta
Journal: Headache Date: 1978-05 Impact factor: 5.887

9. Further studies concerning the toxicity of ingested ergot sclerotia (Claviceps purpurea) to young and growing pigs.

Authors: C T Whittemore; J K Miller; P G Mantle
Journal: Res Vet Sci Date: 1977-03 Impact factor: 2.534

10. Systemic availability of ergotamine tartrate after oral, rectal and intramuscular administration.

Authors: V Ala-Hurula; V V Myllylä; P Arvela; J Heikkilä; N Kärki; E Hokkanen
Journal: Eur J Clin Pharmacol Date: 1979-02-19 Impact factor: 2.953

10 in total

12 in total

1. Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors.

Authors: M O den Boer; J P Heiligers; P R Saxena
Journal: Br J Pharmacol Date: 1991-09 Impact factor: 8.739

2. Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing.

Authors: S W Sanders; N Haering; H Mosberg; H Jaeger
Journal: Eur J Clin Pharmacol Date: 1986 Impact factor: 2.953

3. Correlation between pharmacokinetics and clinical effects of ergotamine in patients suffering from migraine.

Authors: V Ala-Hurula
Journal: Eur J Clin Pharmacol Date: 1982 Impact factor: 2.953

4. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater.

Authors: M G Buzzi; M A Moskowitz
Journal: Br J Pharmacol Date: 1990-01 Impact factor: 8.739